Intravenous Administration Of Rituximab In The Treatment Of Primary Cutaneous B-Cell Lymphomas (Pcbcls): A Retrospective Study

BLOOD(2014)

引用 24|浏览53
暂无评分
摘要
Introduction. Rituximab has been demonstrated to be effective either as intralesional or as systemic therapy in PCBCL, We report our experience in the treatment of PCBCL with intravenous Rituximab.
更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要